Cargando…
Substrate specificity of the cypemycin decarboxylase CypD
The linaridin antibiotic cypemycin is a ribosomal synthesized and post-translationally modified peptide (RiPP) that possesses potent activity against mouse leukemia cells. This peptide natural product contains an S-[(Z)-2-aminovinyl]-d-cysteine (AviCys) moiety in the C-terminus. Formation of AviCys...
Autores principales: | Ding, Wei, Mo, Tianlu, Mandalapu, Dhanaraju, Zhang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190514/ https://www.ncbi.nlm.nih.gov/pubmed/30345401 http://dx.doi.org/10.1016/j.synbio.2018.09.002 |
Ejemplares similares
-
Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD
por: Karch, Jason, et al.
Publicado: (2019) -
Butyrate Feeding Reverses CypD-Related Mitoflash Phenotypes in Mouse Myofibers
por: Li, Ang, et al.
Publicado: (2021) -
Sulphenylation of CypD at Cysteine 104: A Novel Mechanism by Which SO(2) Inhibits Cardiomyocyte Apoptosis
por: Lv, Boyang, et al.
Publicado: (2022) -
SIRT3-Mediated CypD-K166 Deacetylation Alleviates Neuropathic Pain by Improving Mitochondrial Dysfunction and Inhibiting Oxidative Stress
por: Yan, Binbin, et al.
Publicado: (2022) -
3579 The role of CypD/mPTP during osteogenic differentiation - a potential target to prevent bone loss
por: Sautchuk, Rubens, et al.
Publicado: (2019)